Virology News and Research

Latest Virology News and Research

FDA approves CSL's seasonal and H1N1 flu vaccines for children

The U.S. Food and Drug Administration has approved the use of the CSL Limited's seasonal and 2009 H1N1 influenza vaccines to include children ages 6 months and older. These vaccine were previously approved for use in adults, ages 18 years and older

17 Nov 2009

Scientists find major genetic differences between the pandemic H1N1 strain and seasonal strains

As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.

17 Nov 2009

Handwashing: A simple, effective way to prevent the spread of communicable diseases

In this day and age, with the latest in medical equipment and scientific advances adding both quantity and quality to our lives, it is easy to forget that the simplest actions can provide some of the most important results. In fact, your mother's instructions to "wash up before dinner" should be considered some of the soundest medical advice ever offered.

17 Nov 2009

Implementing infection-limiting measures a challenge, say researchers

The H1N1 flu virus is spreading misery around the country, but University of Michigan researchers say that implementing and sustaining infection-limiting measures will still be a challenge.

16 Nov 2009

H1N1 continues to spread, despite leveling off in some regions, WHO reports

Despite reports that the numbers of new H1N1 (swine flu) are leveling off in some parts of the Northern Hemisphere, the virus continues to spread, the WHO said Friday, Reuters reports. "In an update on the H1N1 swine flu virus, the WHO said parts of the southern and southeastern United States, as well as Iceland and Ireland, seemed to have weakening levels of disease after an unusually early start of the winter flu season," the news service writes.

16 Nov 2009

Additional vaccine for 2009 H1N1 flu approved by FDA

The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.

16 Nov 2009

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

The 11th annual research conference of the Ontario HIV Treatment Network will examine the factors that increase risk for individuals and communities most affected by HIV, as well as interventions that may improve the lives of people living with HIV and prevent the spread of the virus.

16 Nov 2009

Researchers discover new immune mechanism against viruses

Viruses are microscopically sized parasites. They plant their genes in the cells of their victim in order to 'reprogram' them. The infected cells then no longer produce what they need to live, making lots of new viruses instead.

16 Nov 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

Department of Health to conduct statewide clinics to administer free H1N1 vaccine

The Department of Health today announced it will conduct statewide clinics from Nov. 20-22 to administer free H1N1 vaccine to individuals in the recommended target groups that have not had previous access to the vaccine.

16 Nov 2009

NIDA awards $17 million to University of California to establish TMARC

Igor Grant, MD, professor of psychiatry at the University of California, San Diego School of Medicine, and colleagues have been awarded a $17 million grant from the National Institute on Drug Abuse to establish the Translational Methamphetamine AIDS Research Center (TMARC) at UC San Diego. Grant is director of the HIV Neurobehavioral Research Center (HNRC), a clinical research center designated and funded by the National Institute of Mental Health.

16 Nov 2009

WHO revises clinical H1N1 guidelines, sends antivirals to some hard-hit nations

On Thursday, the WHO issued revised guidance for the clinical management of H1N1 (swine) flu, the Associated Press reports. According to the AP, the WHO "says doctors shouldn't wait for lab confirmation before giving anti-viral drugs to pregnant women and other at-risk groups with suspected swine flu" (11/12).

16 Nov 2009

CDC releases revised H1N1 estimates

USA Today: As expected, CDC released revised H1N1 estimates Thursday indicating that 3,900 people in the U.S. have died from the infection, including 540 children (Sternberg, 11/12).

13 Nov 2009

CaringBridge, a solution to keep patients from feeling isolated during hospital stays

Hospitals are placing higher restrictions on their visitation policies due to the threat of H1N1. While this helps reduce exposure to the virus, it also means that patients will see less of their family and friends, increasing their feeling of isolation.

13 Nov 2009

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Much has been learned about HIV-1, the virus that causes the disease.

13 Nov 2009

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

The U.S. Food and Drug Administration has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

13 Nov 2009

New findings on human genome may be useful for developing specific AIDS drugs

The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations "stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions."

12 Nov 2009

Tips for preventing cancer

The risk of cancer can be dramatically reduced through everyday choices about diet, exercise and tobacco use, according to a Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource.

12 Nov 2009

Virology News and Research

Latest Virology News and Research

FDA approves CSL's seasonal and H1N1 flu vaccines for children

Scientists find major genetic differences between the pandemic H1N1 strain and seasonal strains

Handwashing: A simple, effective way to prevent the spread of communicable diseases

Implementing infection-limiting measures a challenge, say researchers

H1N1 continues to spread, despite leveling off in some regions, WHO reports

Additional vaccine for 2009 H1N1 flu approved by FDA

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

Researchers discover new immune mechanism against viruses

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Department of Health to conduct statewide clinics to administer free H1N1 vaccine

NIDA awards $17 million to University of California to establish TMARC

WHO revises clinical H1N1 guidelines, sends antivirals to some hard-hit nations

CDC releases revised H1N1 estimates

CaringBridge, a solution to keep patients from feeling isolated during hospital stays

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

New findings on human genome may be useful for developing specific AIDS drugs

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

CDC expected to revise estimated number of U.S. H1N1 deaths

Tips for preventing cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production